Global Enterovirus and Parechovirus Testing Market Growth (Status and Outlook) 2023-2029

Global Enterovirus and Parechovirus Testing Market Growth (Status and Outlook) 2023-2029

Enterovirus is a genus of positive-sense single-stranded RNA viruses associated with several human and mammalian diseases. Enteroviruses are named by their transmission-route through the intestine. Parechovirus is a genus of viruses in the family Picornaviridae. Humans, ferrets, and various rodents serve as natural hosts. The genus currently consists of six accepted species. Human parechoviruses may cause gastrointestinal or respiratory illness in infants, and have been implicated in cases of myocarditis and encephalitis.

LPI (LP Information)' newest research report, the “Enterovirus and Parechovirus Testing Industry Forecast” looks at past sales and reviews total world Enterovirus and Parechovirus Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Enterovirus and Parechovirus Testing sales for 2023 through 2029. With Enterovirus and Parechovirus Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enterovirus and Parechovirus Testing industry.

This Insight Report provides a comprehensive analysis of the global Enterovirus and Parechovirus Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enterovirus and Parechovirus Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Enterovirus and Parechovirus Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enterovirus and Parechovirus Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enterovirus and Parechovirus Testing.

The global Enterovirus and Parechovirus Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Enterovirus and Parechovirus Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Enterovirus and Parechovirus Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Enterovirus and Parechovirus Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Enterovirus and Parechovirus Testing players cover Abbexa, Aviva Systems Biology, Creative Diagnostics, CUSABIO Technology, Elitech Group, DiaSorin, Primerdesign, Quidel and BioMerieux, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Enterovirus and Parechovirus Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
RT-PCR
Rapid Test

Segmentation by application
Hospitals
Scientific Research
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbexa
Aviva Systems Biology
Creative Diagnostics
CUSABIO Technology
Elitech Group
DiaSorin
Primerdesign
Quidel
BioMerieux
Cepheid

Please note: The report will take approximately 2 business days to prepare and deliver.